mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |